HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coty

This article was originally published in The Rose Sheet

Executive Summary

Keshi Renjen to exec VP-operations with responsibility for worldwide manufacturing and distribution operations, including logistics, production, purchasing and quality assurance. Renjen moves to the post from Coty senior VP-manufacturing and distribution at the company's Sanford, N.C. facility. Prior to joining Coty, he served as VP-manufacturing operations for L'Oreal, where he spent 14 years. Renjen succeeds Lars Stork who left the company July 1 to pursue other interests

You may also be interested in...



Coty

Brian Harris to The Healing Garden director of marketing with responsibility for the brand's domestic operations. He moves to the firm from Clairol where he served as senior product manager for new hair care products. Harris reports to Teri Seigel, who has been promoted to the post of VP-marketing responsible for The Healing Garden's global business. She advances from senior director of marketing. Separately, Elizabeth Marrone is named VP-product development from group director of product development

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007041

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel